Risk factors for idiopathic myelitis at admission and predictors for late diagnostic change
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 361, 577747
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Infliximab for the treatment of CNS sarcoidosisNeurology, 2017
- Predictors of outcome in a large retrospective cohort of patients with transverse myelitisMultiple Sclerosis Journal, 2017
- Mielitis. Diferencias entre esclerosis múltiple y otras etiologíasNeurología, 2016
- International consensus diagnostic criteria for neuromyelitis optica spectrum disordersNeurology, 2015
- Etiologic Spectrum and Prognosis of Longitudinally Extensive Transverse MyelopathiesEuropean Neurology, 2014
- International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitionsMultiple Sclerosis Journal, 2013
- The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteriaJournal of the European Academy of Dermatology and Venereology, 2013
- Idiopathic acute transverse myelitis: Application of the recent diagnostic criteriaNeurology, 2005
- Proposed diagnostic criteria and nosology of acute transverse myelitisNeurology, 2002
- Acute myelopathies: Clinical, laboratory and outcome profiles in 79 casesBrain, 2001